UC HEALTH LINE: Parkinson's Treatment Side Effect Often Similar to Disease Itself
CINCINNATIUncontrollable movements are one of the most common visible effects of Parkinsons disease. But sometimes involuntary movementsparticularly turning, wiggling or jerking of the neck and upper bodycan actually be a side effect of the very medications used to treat Parkinsons.
This phenomenon, called dyskinesias, may be alleviated by adjusting medication dosage, says UC Parkinsons expert Alberto Espay, MD.
But decreasing medication, he adds, can impact quality of life for patients living with this chronic condition. And adding a medication with antidyskinetic effects often works only in the short-term or causes intolerable side effects.
So, finding ways to manage dyskinesias is something Espay has set out to do. He is leading a study looking at the effectiveness of treating dyskinesias with Botox injectionslike those commonly used to tighten up the skin and remove wrinkles.
Botox has been approved by the Food and Drug Administration (FDA) for the treatment of blepharospasm (involuntary closing of the eyelids), cervical dystonia (involuntary forced muscle contractions in the neck region), hyperhidrosis (excessive sweating) and strabismus (squinting of the eyes). The use of Botox for the treatment of dyskinesias is considered investigational and is not approved by the FDA.
Because these injections have proven successful in the treatment of other, similar conditions, we hypothesize that they will be effective in alleviating dyskinesias in Parkinsons patients, says Espay, assistant professor of neurology at UC and a member of the Neuroscience Institute at UC and University Hospital. This study is the first of several that will be necessary to validate this idea.
Espay will follow two groups of patients for four monthsone group will receive Botox injections, and the other group will get saline injections. After four months, the groups will be switched. The group previously receiving Botox injections will now receive saline and vice versa. Espay and his team will observe each set of participants for another four months, gathering data over the course of the study through a series of office visits, digital video recording and self-evaluation.
Parkinsons disease results from the loss of a group of brain cells that produce the natural neurotransmitter dopamine. Without dopamine, brain nerve cells dont fire properly, causing an inability to control movement.
The most visible signs of the diseasetremors, difficulty with gait and balance, rigidity and stiffness or general slowness when movingare blamed on this lack of dopamine production in the brain.
This research is supported by Allergan.
For more information about the study, call (513) 558-7019.
The university, in partnership with the Health Alliance of Greater Cincinnati, established the Neuroscience Institute in 1998 as part of an effort to build upon its national reputation for excellence in neuroscience. The institute includes or is developing research centers that focus on the main diseases of the brain and nerves such as stroke, brain tumors, brain trauma, Parkinson's, Alzheimer's, epilepsy, ALS and multiple sclerosis.
Tags
Related Stories
UC study: Brain organ plays key role in adult neurogenesis
July 2, 2024
The University of Cincinnati has published research in the Proceedings of the National Academy of Sciences that found the choroid plexus and cerebrospinal fluid play a key role in maintaining a pool of newly born neurons to repair the adult brain after injury.
Put down that beer; it's not a tanning lotion
![WVXU logo](/content/dam/refresh/uc-news/news-icons/dark/wvxu.png)
July 1, 2024
The University of Cincinnati's Kelly Dobos joined WVXU's Cincinnati Edition to discuss what's fact and what's myth when it comes to sunscreen use, different kinds of sunscreen and a social media recommendation to use beer on your skin to help get a tan.
Cincinnati researchers want to know if MRIs can work better
![WVXU logo](/content/dam/refresh/uc-news/news-icons/dark/wvxu.png)
June 28, 2024
WVXU and the Cincinnati Business Courier highlighted a new collaboration between the University of Cincinnati College of Medicine, UC Health GE HealthCare, JobsOhio, REDI Cincinnati and Cincinnati Children’s to create an MRI Research and Development Center of Excellence located on UC’s medical campus.